Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Novel cancer therapies are offering patients new treatments and better outcomes worldwide. And recent changes in healthcare policies across APAC, such as China’s fast tracking approval of therapies for severe and rare diseases, have reignited interest in the APAC region as a strong market for oncology.
Could you nudge your brand to success using behavioural economic theory?
With behavioural economics theory becoming more widely adopted, especially within the market research sector, terms such as ‘nudging’ have started to enter our vocabulary. Director Anthony Greenwood discusses what ‘nudging’ means for market research and the role it could play in marketing pharma and med-tech brands.
PMRC Europe round-up 2018
Earlier this month Director Paula Coyle and Associate Director An-hwa Lee attended the European Pharmaceutical Market Research Conference in Basel, Switzerland.
The event was well-received thanks to an agenda that included many thought-provoking sessions that addressed key industry issues and allowed attendees to enhance their knowledge. On day one of the conference An-hwa presented the paper ‘How to capture rare disease ‘moments-of-truth’ using online communities’ which demonstrated how, with careful set-up and management, online communities can be excellent methods for attaining an in-depth, meaningful understanding of patients with rare diseases. The session was well attended and received positive feedback from delegates.
Can virtual reality revolutionise the way we conduct healthcare market research?
In the final installment of a three-part series exploring immersive technologies, Harrison Gaiger looks at how technological advances in VR/AR are offering new opportunities for conducting healthcare market research.
Given the powerful impact of VR/AR technology and its expanding applications within the healthcare industry, it is easy to imagine the many ways in which VR/AR can be utilised to develop, research, and evaluate product and service innovations. Instead of simply observing how respondents behave, pharmaceutical and MedTech companies now have the ability to understand the reasons why with greater clarity. VR/AR technology presents market researchers with an opportunity to study customers’ behaviour in more depth than ever before and can provide insights that complement those gathered using traditional market research techniques, such as surveys and focus groups.
How we used behavioural economic theory to reveal fresh insights into patient compliance
Our client currently has a product for a chronic rare disease which has seen an initial successful uptake. HCPs appear to support the product and are actively prescribing it to suitable patients.
However, sales data suggests that repeat prescriptions drastically reduce after the first 3-6 months. Although the product has a known SE profile, our client believes that this can be well managed and controlled.